Declaration of Competing Interest statements were not included in the published version of the following articles that appeared in previous issues of North American Spine Society Journal (NASSJ)
The appropriate Declaration/Competing Interest statement, provided by the Authors, are included below.
-
1.
“COVID-19 pandemic and the implications for orthopaedic and neurosurgery residents and fellows on spine rotations” [North American Spine Society Journal (NASSJ), 2020;1: 100006] https://doi.org/10.1016/j.xnsj.2020.100006.
*Declaration of competing interest: O Ramos: Nothing to disclose. A Mierke: Nothing to disclose. M Eastin: Nothing to disclose. M Morrison: Consulting: DePuy Synthes Spine (B), OrthoPediatrics (B); Grants: POSNA (A, Paid directly to institution). DM Wongworawat: Board of Directors: AAOS (Nonfinancial), Alumni Association School of Medicine of Loma Linda University (Nonfinancial), Health Services International (Nonfinancial), Neufeld Society (Alumni Association) (Nonfinancial); ResearchSupport (Investigator Salary, Staff/Materials): Clinical Orthopaedics and Related Research (Nonfinancial). OA Danisa: Royalties: Globus Medical (E); Consulting: SpineArt (B); Scientific Advisory Board: American Board of Orthopaedic Surgeons (B).
-
2.
“Calcium pyrophosphate deposition disease of the cervical and thoracolumbar spine: A report of two cases.” [North American Spine Society Journal (NASSJ), 2020;3: 100026] https://doi.org/10.1016/j.xnsj.2020.100026.
*Declaration of competing interest: A Moon: Nothing to disclose. S Mabry: Nothing to disclose. J Pittman: Nothing to disclose.
-
3.
“A prospective, single arm study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 12-month results” [North American Spine Society Journal (NASSJ), 2020;3: 100030] https://doi.org/10.1016/j.xnsj.2020.100030.
*Declaration of competing interest: B Boody: Grant: Relievant Medsystems (B, paid directly to institution). Consulting: Medicrea, Medtronic (B). D Singh: Nothing to disclose. E Pena: Nothing to disclose. J Arbuckle: Nothing to disclose. J. Gentile: Nothing to disclose. K Macadeg: Nothing to disclose. R Funk: Nothing to disclose. S Vinayek: Nothing to disclose. E Truumees: Trips/Travel Reimbursement: NASS, AAOS (B); Research Support: Relievant (F, paid directly to institution).
*NASS Disclosure Key:
Degree of support:
Level A. $100 to $1000
Level B. $1,001 to $10,000
Level C. $10,001 to $25,000
Level D. $25,001 to $50,000
Level E. $50,001 to $100,000
Level F. $100,001 to $500,000
Level G. $500,001 to $1M
Level H. $1,000,001 to $2.5M
Level I. greater than $2.5M